These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35350019)

  • 1. A Case-Control Study of the Luteinizing Hormone Level in Luteinizing Hormone Receptor Gene (rs2293275) Polymorphism in Polycystic Ovarian Syndrome Females.
    Atoum MF; Alajlouni MM; Alzoughool F
    Public Health Genomics; 2022 Mar; ():1-9. PubMed ID: 35350019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome.
    Thathapudi S; Kodati V; Erukkambattu J; Addepally U; Qurratulain H
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):128-32. PubMed ID: 25565299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.
    Makhdoomi MJ; Shah IA; Rashid R; Rashid A; Singh S; Shah ZA; Ganie MA
    Biochem Genet; 2023 Aug; 61(4):1418-1432. PubMed ID: 36633772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of LHCGR variants and polycystic ovary syndrome in Punjab: a case-control approach.
    Singh S; Kaur M; Kaur R; Beri A; Kaur A
    BMC Endocr Disord; 2022 Dec; 22(1):335. PubMed ID: 36585675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
    El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
    IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
    Saadia Z
    Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interplay of Progesterone, Leukemia Inhibitor Factor and Interleukin-6 in the window of implantation; Impact on fertility.
    Ali R; Ahmed Khan T; Gul H; Rehman R
    Cytokine; 2023 Oct; 170():156332. PubMed ID: 37586287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
    Kordestani F; Mazloomi S; Mortazavi Y; Mazloomzadeh S; Fathi M; Rahmanpour H; Nazarian A
    BMC Med Genet; 2018 Aug; 19(1):149. PubMed ID: 30134857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of
    Singh N; Mishra N; Dogra Y
    J Hum Reprod Sci; 2021; 14(1):21-27. PubMed ID: 34083988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
    BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.
    Chun S
    Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women.
    Alhassan S; Elmugadam A; Elfadil GA; Abubaker N; Elfaki EM; Hamza A; Abdalhabib EK; Karar T
    Int J Womens Health; 2023; 15():837-843. PubMed ID: 37275514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.